Open Innovation

Partnering is the secret to winning the Open Innovation Lottery.

A Kinapse White Paper
Written by Adrian Leibert

What are the ways to overcome challenge?

Bringing novel therapies to market and having complete access to expertise constitute essential challenges for drug institutions.

Open Innovation brings the value of effective partnering. Companies rely to each other to accelerate internal innovation and follow the same paths to strategically advance their technologie. The combination with drug repurposing requires access to highly specialised skills and at the same time offers a source of development options and activities to any institution. 

Why do many big pharmaceutical companies have business units specifically aimed at drug repurposing? A long-term Kinapse partnership, which has supported numerous drug repurposing trials led us to specific conclusions. To get an overview download our white paper and acquire more knowledge about the different partnering fields.  

Fill in the form above to download this free white paper and read the full details.

Download your copy

Unless you have previously signed up to marketing emails, we will delete your data after delivering your copy of the white paper. For full details, read our Privacy Policy.

Full Width Content